Health

All Health

  • Mutations drive malignant melanoma

    Two mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what Harvard scientists call the “dark matter” of the cancer genome, where cancer-related mutations haven’t been previously found.

  • New avenue in neurobiology

    Harvard stem cell biologists have proven that it is possible to turn one type of already differentiated neuron into another inside the brain, and their findings may have enormous implications for the treatment of neurodegenerative diseases.

  • A hidden genetic code

    For decades, scientists wondered whether there was some subtle difference between parts of the genetic code that, while different, appear to encode the same amino acid. Harvard researchers now have the answer.

  • Plant power

    The world we live in was made possible by the precursors to plants, which crossed two evolutionary hurdles that transformed not only plant life, but also the Earth’s atmosphere and its once-barren continents, Arnold Arboretum Director William Friedman said in a recent lecture.

  • Digging yields clues

    As described in a Jan. 16 paper in Nature, a team of researchers led by Hopi Hoekstra, professor of organismic and evolutionary biology and molecular and cellular biology, studied two species of mice – oldfield mice and deer mice – and identified four regions in their genome that appear to influence the way they dig their burrows.

  • In Africa, success against AIDS

    AIDS researchers gathered at the Harvard School of Public Health to mark 10 years of work under a landmark federal anti-AIDS program that has led to significant progress against the epidemic.

  • ‘Whole grain’ not always healthy

    U.S. Department of Agriculture’s 2010 Dietary Guidelines recommend that Americans consume at least three servings of whole-grain products daily, and the new U.S. national school lunch standards require that at least half of all grains be whole-grain rich. However, no single standard exists for defining any product as a “whole grain,” according to a Harvard School of Public Health study.

  • Pill-sized device rivals endoscopy

    Physicians may soon have a new way to screen patients for Barrett’s esophagus, a precancerous condition usually caused by chronic exposure to stomach acid. Harvard researchers at the Wellman Center for Photomedicine at Massachusetts General Hospital have developed an imaging system enclosed in a capsule about the size of a multivitamin pill that creates detailed, microscopic images of the esophageal wall.

  • Looming malpractice

    The average physician will spend more than 10 percent of his or her career facing an open malpractice claim. Some specialists will spend upwards of 27 percent.

  • Push for name-brand drugs

    More than a third of U.S. physicians responding to a national survey indicated they prescribed brand-name drugs when appropriate generic substitutes were available.

  • One cell is all you need

    Scientists at Harvard have pioneered a breakthrough technique that can reproduce an individual’s entire genome from a single cell. The development could revolutionize everything from cancer treatment, by allowing doctors to obtain a genetic fingerprint of a person’s cancer early in treatment, to prenatal testing.

  • A treatment for ALS?

    According to researchers, results from a meta-analysis of 11 independent amyotrophic lateral sclerosis (ALS) research studies are giving hope to the ALS community by showing, for the first time, that the fatal disease may be treatable.

  • Battling a bacterial threat

    Harvard physicians and scientists are joining forces to tackle one of the most troubling developments on the medical landscape: the rise of drug-resistant bacteria.

  • Problem with generic meds

    Researchers from Harvard-affiliated Brigham and Women’s Hospital have found that some patients who receive generic drugs that vary in their color are over 50 percent more likely to stop taking the drug, leading to potentially important and potentially adverse clinical effects.

  • Sniff mechanics

    As described in a Dec. 19 paper in Neuron by Venkatesh Murthy, a professor of molecular and cellular biology, researchers have, for the first time, shed light on how the neural feedback mechanism of the olfactory system works by identifying where the signals go, and which type of neurons receive them.

  • Battle cries of freedom

    A Countway Library exhibit at Harvard Medical School brings the suffering of the Civil War to light.

  • Extra chemo could be answer

    Researchers have found that young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy.

  • Solving a biological mystery

    A team of Harvard researchers has shown that insects like crickets possess a variation of a gene — called oskar — that is critical to the production of germ cells in “higher” insects. That discovery suggests that the oskar gene emerged far earlier in insect evolution than researchers previously believed.

  • The bounty of EDEN

    An associate professor at Harvard, Cassandra Extavour also heads up the Evo-Devo-Eco Network (EDEN), a collaborative group of researchers devoted to encouraging the study of nontraditional “model” organisms, ranging from sea anemones and crickets.

  • Birth of new cardiac cells

    In a study from Harvard-affiliated Brigham and Women’s Hospital, researchers used a novel method to identify the new heart cells and describe their origins.

  • The ants come marching

    Aaron Ellison, a senior research fellow in ecology at Harvard Forest, has co-authored a new book, “A Field Guide to the Ants of New England.” During a discussion, he explained their pivotal importance to nature.

  • ‘Stem cell tourism’ growing trend

    A Harvard panel examined the problem of clinics around the world that provide stem cell treatments for intractable conditions. Although there is no medical evidence of the treatments’ effectiveness, such clinics have drawn thousands of patients from many countries.

  • Sophisticated worms

    In a new study of worm locomotion, researchers show that a single type of motor neuron drives an entire sensorimotor loop.

  • TB test offers rapid results

    A new rapid test for tuberculosis (TB) could substantially and cost-effectively reduce TB deaths and improve treatment in southern Africa — a region where both HIV and tuberculosis are common — according to a new study by Harvard School of Public Health researchers

  • Glimpses of paradise

    Photographer and Harvard affiliate Tim Laman worked with Edwin Scholes of the Cornell Laboratory of Ornithology to document all 39 species of birds of paradise.

  • NFL chief talks player safety at HSPH

    NFL Commissioner Roger Goodell highlighted recent moves to make the game safer and affirmed a commitment to player safety Thursday (Nov. 15) during a talk at the Harvard School of Public Health.

  • New views on deadly diseases

    Harvard researchers are challenging the popular portrayal of Ebola and other viral hemorrhagic fevers. In a new paper in Science, researchers present evidence that the diseases may be more common — and much older — than previously thought.

  • An experiment gone horribly awry

    Victims of U.S. syphilis experiments in Guatemala are still awaiting compensation that may or may not come, even as new laws passed in the wake of 9/11 make it harder, in some circumstances, to sue disease researchers for wrongdoing, panelists at Harvard Law School said.

  • Meditation’s positive residual effects

    A new study has found that participating in an eight-week meditation training program can have measurable effects on how the brain functions even when someone is not actively meditating.

  • Green light for Obamacare

    Health care specialists discussed post-election Obamacare, including potential bumps in the road, in a panel talk at the Harvard School of Public Health.